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Introduction: Opioid overdose deaths quintupled in Massachusetts between 2000 and 2016. Potentially in-
appropriate opioid prescribing practices (PIP) are associated with increases in overdoses. The purpose of this
study was to conduct spatial epidemiological analyses of novel comprehensively linked data to identify overdose
and PIP hotspots.
Methods: Sixteen administrative datasets, including prescription monitoring, medical claims, vital statistics, and
medical examiner data, covering> 98% of Massachusetts residents between 2011–2015, were linked in 2017 to
better investigate the opioid epidemic. PIP was deﬁned by six measures:≥100 morphine milligram equivalents
(MMEs), co-prescription of benzodiazepines and opioids, cash purchases of opioid prescriptions, opioid pre-
scriptions without a recorded pain diagnosis, and opioid prescriptions through multiple prescribers or phar-
macies. Using spatial autocorrelation and cluster analyses, overdose and PIP hotspots were identiﬁed among 538
ZIP codes.
Results: More than half of the adult population (n=3,143,817, ages 18 and older) were prescribed opioids.
Nearly all ZIP codes showed increasing rates of overdose over time. Overdose clusters were identiﬁed in
Worcester, Northampton, Lee/Tyringham, Wareham/Bourne, Lynn, and Revere/Chelsea (Getis-Ord Gi*;
p < 0.05). Large PIP clusters for ≥100 MMEs and prescription without pain diagnosis were identiﬁed in
Western Massachusetts; and smaller clusters for multiple prescribers in Nantucket, Berkshire, and Hampden
Counties (p < 0.05). Co-prescriptions and cash payment clusters were localized and nearly identical
(p < 0.05). Overlap in PIP and overdose clusters was identiﬁed in Cape Cod and Berkshire County. However, we
also found contradictory patterns in overdose and PIP hotspots.
Conclusions: Overdose and PIP hotspots were identiﬁed, as well as regions where the two overlapped, and where
they diverged. Results indicate that PIP clustering alone does not explain overdose clustering patterns. Our
ﬁndings can inform public health policy decisions at the local level, which include a focus on PIP and misuse of
heroin and fentanyl that aim to curb opioid overdoses.
Introduction
Since 2000, the opioid epidemic has taken a severe toll across the
United States (US). Opioid prescription rates have increased nearly
threefold in the last 15 years—alongside an increase in opioid related
overdoses and deaths (Sun et al., 2017). In the US, drug overdose has
become the leading cause of accidental death. Of the estimated 52,404
lethal drug overdoses in 2015, 20,101 were related to the use of pre-
scription pain relievers (Rudd, Seth, David, & Scholl, 2016).
Massachusetts has been particularly aﬄicted by the opioid epi-
demic. Massachusetts is one of 19 states with a statistically signiﬁcant
increase in overdose deaths from 2014 to 2015 (Sun et al., 2017).
Opioid-related mortality rates in Massachusetts have increased by
478% between 2000 and 2016, a rate several times faster than any
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previously experienced in the state (MDPH, 2017c). All Massachusetts
counties and municipalities have been aﬀected by the opioid epidemic
in some form, but impact varies by region (MDPH, 2017b). Between
2011 and 2015, the overall state rate for opioid overdose was 15.4
deaths per 100,000 residents, which was higher than the national rate
of 10.4 per 100,000 (Rudd et al., 2016). Since 2013, the rising overdose
death numbers have been driven by the introduction of illicitly pro-
duced fentanyl in the opioid drug supply (Gladden & Martinez, 2016;
Marshall, Krieger et al., 2017).
However, few people start using opioids by experimenting with
heroin or illicit fentanyl. About 80% of people who use heroin report
starting with the use of prescription opioids (Jones, 2013). Under-
standing prescription opioid acquisition patterns is important to pre-
vent potential addiction.
In response to the dramatic increase in overdose deaths, political
leaders across the US have begun to work together in an eﬀort to curb
the epidemic (NGA, 2018). In Massachusetts, the legislature and Gov-
ernor Baker established a new legislative mandate. Chapter 55 of the
Acts of 2015, enacted in August 2015, mandated the analysis of data
from several Massachusetts government agencies to identify and report
on trends among persons who suﬀered a fatal opioid overdose. This was
later expanded to also include non-fatal overdose. This novel and
comprehensive linkage across datasets at the individual level allowed
analysts to gain a deeper understanding of the circumstances that in-
ﬂuenced fatal and non-fatal opioid overdoses. Through this work,
public health and other policymakers were able to gain greater insight
on the opioid epidemic, guide policy development and inform pro-
grammatic decisions (MDPH, 2017a).
Potentially inappropriate opioid prescribing (PIP) describes speciﬁc
opioid prescribing practices that could lead to adverse drug events and
health complications (Clyne, Bradley, & Hughes, 2013; Rochon, Lane, &
Bronskill, 2004; Logan, Liu, Paulozzi, Zhang, & Jones, 2013). PIP has
been studied for many drug classes in elderly populations, where risk
for PIP is high, but less is known about the speciﬁc role of PIP in the
Massachusetts opioid epidemic (MDPH, 2017a). Identifying opioid re-
lated PIP and determining what role PIP plays in opioid overdose is
important to improving the safety of pain treatment. Little is known
about the geographic distribution of PIP and opioid overdose.
In this study, we used geographic information systems (GIS) and
spatial epidemiological analyses to characterize the geographic dis-
tribution of fatal opioid overdoses and PIP across Massachusetts. Our
objectives were to create descriptive and hotspot cluster analysis maps
to better understand the landscape of opioid epidemic outcomes and
predictors to test the hypothesis that opioid overdoses and PIP cluster
geospatially, and to assess potential overlap between overdose and PIP
hotspots to inform public health and clinical responses.
Methods
Dataset and measures
Through Chapter 55 of the Acts of 2015, the Massachusetts
Department of Public Health linked sixteen administrative datasets,
including prescription monitoring program (PMP), medical claims, vital
statistics, and medical examiner data. The study population was deﬁned
as Massachusetts residents ages 18 and above with at least one opioid
prescription throughout the 5-year study period, 2011–2015
(n=3,143,817), with the exclusion of those who had late stage cancer
diagnoses recorded in the State’s cancer registry. We conducted ana-
lyses elsewhere focused on the associations between PIP, overdose
deaths, and all-cause mortality (Rose, Bernson, & Chui, 2018).
PIP deﬁnitions
We deﬁned opioid PIP in Massachusetts based on six criteria, es-
tablished through literature review and consultation with experts in the
ﬁeld: (1) ≥100 morphine milligram equivalents (MMEs) per day in at
least three months, (2) receipt of opioid prescriptions in three con-
secutive months without ever recording a pain diagnosis in claims data,
(3) three or more cash purchases of opioid prescriptions, (4) opioid
prescriptions obtained at four or more distinct pharmacies in a quarter
(5) opioid prescriptions obtained from four or more distinct prescribers
in a quarter, and (6) co-prescription of benzodiazepines and opioids in
at least three months (Rose, Bernson, & Chui, 2018). Initial database
linkage, data cleaning, and variable creation were performed in SAS
Studio (v3.5, Cary, NC).
Geographic analysis
We aggregated all PIP and overdose events at the ZIP code level and
joined these data to a geographic shapeﬁle for all ZIP code tabulation
areas in Massachusetts (n= 538). To ensure conﬁdentiality in de-
scriptive maps, we suppressed PIP data for ZIP codes with small num-
bers following Massachusetts Department of Public Health (MDPH)
conventions. Missing or suppressed data can hinder cluster analyses
because they disrupt geographic neighborhoods. To combat this issue
for variables with suppressed data, we substituted the midpoint value
for the suppression range for each ZIP code in cluster analysis. Final
cluster analyses cannot be traced back to the individual, thus main-
taining conﬁdentially.
Descriptive statistics
In Table 1, we present summary statistics for PIP and fatal opioid
overdose rates in Massachusetts. We highlight our outcome categor-
ization scheme to provide deﬁnitions for low, average, and high rates to
place our thematic map cut points in context (Table 1).
Descriptive mapping
We developed descriptive GIS maps to portray PIP and overdose
counts, and the percent of the study population (adult residents with an
opioid prescription) who experienced PIP. When appropriate, we cal-
culated rates of overdose and PIP variables per 100,000 residents using
ZIP code level population counts in the denominator. In these instances,
our denominator was the 5-year estimate of the average population of
each ZIP code over the ﬁve years, which we multiplied by ﬁve to ac-
count for study duration, in order to calculate a person-year denomi-
nator. We obtained the population denominator data from the U.S.
Census Bureau’s American Community Survey (ACS) (United States
Census Bureau, 2019). We excluded ZIP codes with a 5-year population
estimate< 50 to avoid skewing rate calculations. We developed a re-
ference map of Massachusetts, highlighting the 14 counties and 351
municipalities across the state helping to situate subsequent overdose
and PIP maps (Appendix 1). All descriptive maps were created using
ArcGIS version 10.4.1 (Esri, Redlands, CA).
Spatial cluster analyses
We conducted hotspot cluster analyses to identify statistically sig-
niﬁcant clusters of opioid overdose deaths and PIP, using a ﬁve-step
geoprocessing approach employed previously to assess disease clus-
tering and public health unmet needs (Stopka, 2014; Stopka, Krawczyk,
Gradziel, & Geraghty, 2014). We conducted local indicators of spatial
autocorrelation (LISA) analyses to corroborate our hotspot cluster
analyses, and to identify outlier communities with regard to opioid
overdose deaths (Anselin, 1995). Our hotspot cluster and LISA analy-
tical methods are described in greater detail in Appendix 2.
Results
More than half of the adult population (n=3,143,817) in
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Massachusetts were prescribed opioids at least once between 2011 and
2015. In trend analyses, we found that the number of fatal opioid
overdoses among Massachusetts residents who received an opioid pre-
scription rose steeply and consistently during the study period, from
614 in 2011 to 1590 in 2015. Fatal opioid overdose rates in this po-
pulation also rose steadily and signiﬁcantly over the course of the study
period, from 19.5 deaths per 100,000 in 2011 to 50.5 deaths per
100,000 in 2015 (p < 0.05) (Appendix 3).
Overdose deaths
Nearly all ZIP codes showed increasing rates of overdose deaths
between 2011–2015, many well above national and state average rates.
In Fig. 1a–e, we present descriptive maps that depict annual fatal
overdose rates from 2011 to 2015, and in Fig. 1f we show aggregated
overdose rates across the entire timeframe. We noted steady increases
in overdose death rates across an increasing number of ZIP codes be-
tween 2011 and 2015. By 2015, we found that 51.3% of ZIP codes
(n= 276) had fatal overdose rates that surpassed the national opioid
overdose rate of 10.4 deaths per 100,000 residents (Fig. 1e).
In Fig. 2, we present results of our cluster analyses. We identiﬁed six
statistically signiﬁcant hotspot clusters for fatal overdose rates in the
municipalities of Worcester, Northampton, Lee/Tyringham, Wareham/
Bourne, Lynn, and Revere/Chelsea (p < 0.05) (Fig. 2). We identiﬁed
communities that were spared from high overdose rates in Western
Massachusetts and the Metro West area, to the west of Boston and east
of Worcester, where we identiﬁed lower overdose rates (Fig. 1) and the
presence of overdose coldspots (p < 0.05) relative to all other ZIP
codes in the state (Fig. 2). Hotspots and coldspots were deﬁned as
geographically contiguous regions of ZIP Code Tabulation Areas
(ZCTAs) with statistically signiﬁcant Getis-Ord statistics.
Potentially inappropriate prescribing (PIP)
We depict the spatial distribution of six subtypes of PIP across
Massachusetts in Fig. 3. In Fig. 3a–e, we noted initial patterns in the
spatial distribution of PIP outcomes across Massachusetts, with lower
percentages of people experiencing PIP in the Greater Boston area. The
percentages of people experiencing PIP appeared to increase moving
east to west across the state, as noted by darker shading, or entry into
the upper quintiles for PIP rates.
In Fig. 4, we present results from PIP hotspot analyses. We identiﬁed
clusters for cash payments and co-prescription of opioids and benzo-
diazepines in North Adams, Lee, Blandford, Boxford, Martha’s Vine-
yard, and Nantucket (p < 0.05). For multiple prescribers (i.e., “doctor
shopping”), excessive MME dosing, and prescription without a docu-
mented pain diagnosis, we observed sizeable hotspot clusters in Wes-
tern Massachusetts (p < 0.05). Of note, we observed no clusters when
analyzing the use of four or more pharmacies for opioid prescriptions.
PIP and fatal opioid overdose clustering patterns were most similar
when comparing cash payments for opioid prescriptions (Fig. 4a), co-
prescription of opioids and benzodiazepines (Fig. 4b), and fatal over-
doses (Fig. 2). Cluster maps for all three of these outcomes portrayed
hotspots in Cape Cod and Berkshire County.
Discussion
Opioid prescriptions have been an increasing concern among public
health oﬃcials during the past decade. GIS and spatial epidemiological
analyses are an important tool to better understand opioid epidemic
outcomes and risk factors. We employed a mix of descriptive GIS
mapping techniques and spatial epidemiological analyses to better
understand the geographic landscape of fatal opioid overdose deaths
and PIP across the state of Massachusetts, using a novel comprehen-
sively linked dataset that was created in response to a recent legislative
mandate (MDPH, 2017a). Assessing the geographic distribution ofTa
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Fig. 1. Fatal opioid overdose rates per 100,000 Massachusetts residents, 2011–2015. Rates are aggregated at the ZIP code level. Overdose rates are categorized
with reference to state (15.4 deaths/ 100,000 residents) and national (10.4 deaths/ 100,000 residents) overdose rates. The lightest reds represent ZIP codes with fatal
overdose rates lower than that national average, whereas the darkest red accounts for rates higher than the national and Massachusetts state average. Town/city
boundaries are outlined in black. A) 2011; B) 2012; C) 2013; D) 2014; E) 2015; F) Aggregated/average annual fatal overdose rate per 100,000 Massachusetts
residents, (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article).2011–2015.
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opioid-related PIP can assist policymakers in identifying locations for
targeted public health interventions.
Our ﬁndings provide a unique picture of the Massachusetts epi-
demic. A number of previous studies have presented maps of overdose
in diﬀerent parts of the US (Cerdá, Gaidus, & Keyes, 2017; Marshall,
Krieger et al., 2017; Marshall, Yedinak et al., 2017). Several studies
have assessed PIP (Bohnert, Valenstein, & Bair, 2011; Clyne et al., 2013;
Rochon et al., 2004), and its associations with overdose deaths (Rose,
Bernson et al., 2018), but we are unaware of any that have juxtaposed
opioid overdose deaths and PIP. Our study is one of the ﬁrst to identify
local geographic changes in overdose deaths over time during the re-
cent acceleration of the opioid epidemic. Through our spatial cluster
analyses, we have been able to pinpoint local areas of elevated concern,
as well as areas of low risk relative to their surroundings.
We were able to map six PIP variables at the neighborhood level.
Cash payments and opioid prescription without a documented pain
diagnosis were two PIP subtypes that had not been examined by pre-
vious studies. We identiﬁed several PIP variables (multiple prescribers,
excessive MME, opioid prescription with no pain diagnosis) that were
characterized by systematic hotspot clustering in Western MA and
coldspot clustering in Eastern MA, with exceptions in Boxford, Cape
Cod, and its neighboring islands. While our descriptive maps high-
lighted the growing ubiquity of opioid overdose deaths across the state,
we identiﬁed fatal overdose clusters in urban (Boston metro, Worcester,
Fall River, New Bedford), suburban (Bourne, Wareham, Northampton),
and rural locations of the state (Lee, Tyringham). We identiﬁed similar
clustering patterns for fatal opioid overdoses and two PIP varia-
bles—cash payments for opioid prescriptions and co-prescription of
opioids and benzodiazepines. However, the relationship between other
PIP variable clusters and overdose clusters was not consistent
throughout the state. This emphasizes the point that PIP is only one
factor of many that may explain the geospatial variation in overdose
rates across the state. Focusing on PIP alone from a geospatial per-
spective is not enough to inform all targeted overdose prevention in-
terventions. Recent studies focused on Eastern Massachusetts found
that the proportion of opioid overdose deaths attributed to fentanyl
increased from 32% during 2013–2014 to 74% during early 2016,
(Somerville, O’Donnell, & Gladden, 2017) and that fentanyl was easily
accessible at low cost (Ciccarone, Ondocsin, & Mars, 2017). In other
recent studies, we found that older adults were more likely to be ex-
posed to PIP (Rose, McBain, & Schuler, 2018), and that younger adults
were less likely to experience PIP prior to opioid overdose death
(Larochelle, Bernson, & Land, 2018), which may also contribute to
diﬀerential spatial distributions of PIP and overdose clusters. In areas
where fentanyl is prevalent in the drug supply, or where eﬀective in-
terventions have been implemented, geospatial PIP indicators may play
a limited or more nuanced role in the geographic distribution of fatal
opioid overdoses. Recent research also points to the “triple wave”
theory to describe the opioid overdose crisis in the U.S (Ciccarone,
2018). In testimony before the U.S. House of Representatives, Ciccarone
described the three waves of the overdose epidemic, including: 1) the
rise in opioid prescriptions (within which PIP is situated); 2) a “tigh-
tening” of opioid prescribing habits, resulting in less access to pre-
scription opioids concurrent with an increase in heroin use and misuse;
(Kolodny, Courtwright, & Hwang, 2015) and, 3) the entry of fentanyl
into opioid markets (Ciccarone, 2018). The three waves of overdoses
from prescription opioids to heroin to fentanyl build oﬀ of one another
and they interact in complex ways, while social and economic factors
may also come into play (Dasgupta, Beletsky, & Ciccarone, 2018). The
triple wave theory may help to explain the paradoxical relationship
between PIP hotspots and overdose hotspots, where overdose clusters
are driven largely by the entry of fentanyl into the drug market be-
ginning in 2013.
In our LISA maps, in addition to identifying clusters, we were able to
locate outliers—communities with high overdose rates surrounded by
communities with low overdose rates, and communities with lower
overdose rates surrounded by communities with higher overdose rates.
Municipalities that are outliers on either extreme are worthy of further
investigation to determine why they are diﬀerent from their neighbors.
Several ZIP codes surrounding Northampton, Lee, and in the northwest
Fig. 2. Clustering of fatal opioid overdose rates per 100,000 residents, by Massachusetts ZIP codes, 2011–2015. A) Statistically signiﬁcant clusters of opioid
overdose rates. Red shading highlights signiﬁcant clusters of ZIP codes with elevated overdose rates (p < 0.5); orange shading highlights marginally signiﬁcant
clusters of ZIP codes with elevated overdose rates (p < 0.2); yellow shading represents average opioid overdose rates; light blue highlights marginally signiﬁcant
clusters of ZIP codes with overdose rates that are lower than the state average (p < 0.2); blue shading represents signiﬁcant clustering of ZIP codes with lower
overdose rates than the state average (p < 0.05); B) Local Incremental Spatial Autocorrelation (LISA) cluster map highlighting ZIP codes with high fatal overdose
rates per 100,000 population that are surrounded by neighboring ZIP codes with high overdose rates (red), ZIP codes with low overdose rates that are surrounded by
neighboring ZIP codes with low overdose rates (blue), ZIP codes with high overdose rates that are adjacent to ZIP codes with low overdose rates (pink), and ZIP codes
with low overdose rates that adjacent to neighboring ZIP codes with high overdose rates (purple; p < 0.05). (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article).
T.J. Stopka, et al. International Journal of Drug Policy 68 (2019) 37–45
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corner of Massachusetts appear as such outliers. In Northampton, for-
midable harm reduction programs may have helped to curb overdose
deaths in some ZIP codes, despite high overdose rates in neighboring
ZIP codes. Local and state departments of public health, as well as re-
searchers, may be able to use this information to identify places in need
of a greater response, and places to be studied for their successes in
buﬀering the eﬀects of the opioid epidemic.
Maps move the dial through their power as communication devices.
It is, at times, easier for lay audiences to understand and engage when
examining a map that visualizes a statistic rather than presenting sta-
tistics in tabular form. This is beneﬁcial for two reasons. First, the in-
formation can reach a broader audience, increasing awareness of the
problem and its contributing factors. Second, the visual aspect of maps
facilitates discussion about next steps, leads to new questions from
community members and stakeholders, and can help generate hy-
potheses for researchers. Maps that depict the geospatial landscape with
regard to PIP risks and fatal overdose, for instance, allow community
members to observe high risk activities and outcomes that impact their
neighborhoods and families, which can spawn local organizing and
policy actions. In a comprehensive approach, PIP maps can, in part,
provide policymakers with ﬁndings that can facilitate targeted feedback
and education to prescribers and pharmacists in areas identiﬁed as PIP
hotspots. However, it is important to bear in mind that single policy
eﬀorts (e.g., opioid prescription reform) can have paradoxical eﬀects if
the intertwined aspects of the triple wave of opioid overdose deaths are
not fully recognized, understood, or intervened upon in a comprehen-
sive fashion. Thus, spatial epidemiological and statistical models that
look at PIP (Wave 1), heroin (Wave 2), and fentanyl-related overdoses
(Wave 3) in unison may provide the best opportunity to inform mul-
tifaceted responses that address the triple threat.
Our ﬁndings should be considered in light of several limitations.
First, in reference to data, access to the Chapter 55 dataset allowed us to
conduct analyses at the ZIP code level—a level of granularity not pre-
viously analyzed in Massachusetts. Although census tract level data
would be preferable in terms of increased granularity, Chapter 55 sti-
pulations prevented us from accessing data below the ZIP code level.
Second, ZIP code boundaries vary over time with changing Postal
Service distribution routes (Zhu, Waller, & Ma, 2013). We utilized
ZCTAs in our geographic analysis to control for this change over time.
ZCTAs are calculated using census data and thus their boundaries only
change every 10 years. However, because of the diﬀerent methods by
which the two boundaries are calculated, there are some instances
when ZIP Codes are not represented by ZCTAs and data may not be
included in the geospatial analysis (Grubesic & Matisziw, 2006). It is
important to note that rates of opioid prescribing are calculated using
ZIP Code level values in the numerator and ZCTA population values in
the denominator, which may cause some slight mismatch. Third, it is
possible that some deaths were misclassiﬁed and not considered opioid-
related overdoses if they were not referred to the medical examiner for
a ﬁnal cause of death determination (Rockett, Hobbs, & Wu, 2015). It is
probable, however, that potential misclassiﬁcations are non-diﬀerential
across ZIP Codes in the state. Finally, the Chapter 55 Act and sub-
sequent access to this linked data remains unique to Massachusetts.
Results may not be generalizable to other states in the US. Future re-
search that employs GIS and spatial analytical approaches from the
current study should be replicated elsewhere with similarly linked data
to compare results.
In future research we plan to identify geographic areas in greatest
need of public health intervention with regard to overall opioid burden
based on composite measures, as well as need for increased access to
services (e.g., naloxone distribution, substance use treatment programs,
medications for opioid use disorder, harm reduction programs, syringe
services programs, pharmacies, prison release and re-entry programs).
Additional data could strengthen these analyses, including spatially
oriented data on overdose deaths by drug type (e.g., heroin, fentanyl,
prescription opioids), PIP practices stratiﬁed by age, (Rose, McBain
et al., 2018) pharmaceutical marketing practices, proxies for illicit drug
availability (e.g., arrests and drug seizures), and prevention/interven-
tion capacity (e.g., naloxone utilization, proximity to emergency med-
ical services, treatment or diversion services) to observe potential
spatial associations with overdose. We intend to conduct this research
through the development of statistical models to assess factors asso-
ciated with overdose and other key outcomes to identify additional
touchpoints for intervention.
Further research to develop predictive spatial and statistical ana-
lytical techniques (e.g., geographically weighted regression models;
Bayesian spatiotemporal modeling) is needed to assess opioid epidemic
burden and access to services that could facilitate the prediction of
future hotspots and target future public health interventions. Future
research should also explore diﬀerent imputation methods for sup-
pressed data to better understand its eﬀect on hotspot analysis.
Continued partnership with academic institutions, public health oﬃ-
cials, and governments will aid in combating the opioid crisis in
Massachusetts, the US, and globally.
Conclusion
We used GIS mapping and spatial epidemiological analyses to pin-
point opioid overdose and PIP clusters between 2011 and 2015 using
ﬁrst of its kind comprehensively linked administrative data. We iden-
tiﬁed fatal overdose and PIP hotspots, as well as regions where the two
overlapped, and where they diverged. Our results can inform public
health policy decisions that include a focus on PIP and other compo-
nents of the “triple wave” theory that aim to curb opioid overdose
deaths.
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